Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

Neurotensin Receptor 2 Antibodies

Close filters
No results were found for the filter!
Citations
Immunohistochemical identification of Neurotensin Receptor 2 in gastric mucosa
NTS2 (IHC-grade), Neurotensin Receptor 2 Antibody
The NTS2 antibody is directed against the distal end of the carboxyl-terminal tail of human Neurotensin Receptor 2. It can be used to detect total NTS2 receptors in Western blots independent of phosphorylation. The NTS2 antibody can also...
$ 375.00 *
Citations
Validation of the Neurotensin receptor 2 in transfected HEK293 cells.
NTS2 (non-phospho-Neurotensin Receptor 2 Antibody)
The NTS2 antibody is directed against the distal end of the carboxyl-terminal tail of human Neurotensin Receptor 2. It can be used to detect total NTS2 receptors in Western blots independent of phosphorylation. The NTS2 antibody can also...
$ 375.00 *

The neurotensin type 2 receptor (NTS₂), encoded by NTSR2, is a class A G protein-coupled receptor that recognizes the endogenous peptides neurotensin and neuromedin N. Its signaling properties vary substantially with the species and cellular expression system, with calcium mobilization and ERK1/2 activation reported in experimental models. NTS₂ is expressed in the central nervous system, including the cerebral cortex, hippocampus, cerebellum, and regions involved in pain processing. Animal studies implicate the receptor in neurotensin-mediated analgesia, making it a potential target for non-opioid pain treatment. Agonist stimulation can induce receptor internalization, which contributes to ERK1/2 activation in recombinant rat NTS₂-expressing cells. Levocabastine, a clinically used histamine H₁ antagonist, also binds NTS₂ and displays assay- and species-dependent functional activity. It is used clinically for allergic disorders, while its NTS₂ activity remains primarily of experimental interest. No NTS₂-selective drug is currently approved for therapeutic use. For more information on NTS2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Mazella J, Sarret P, Vincent JP. Neurotensin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4). Available from: https://doi.org/10.2218/gtopdb/F47/2019.4

The neurotensin type 2 receptor (NTS₂), encoded by NTSR2 , is a class A G protein-coupled receptor that recognizes the endogenous peptides neurotensin and neuromedin N. Its signaling properties... read more »
Close window
Neurotensin Receptor 2 Antibodies

The neurotensin type 2 receptor (NTS₂), encoded by NTSR2, is a class A G protein-coupled receptor that recognizes the endogenous peptides neurotensin and neuromedin N. Its signaling properties vary substantially with the species and cellular expression system, with calcium mobilization and ERK1/2 activation reported in experimental models. NTS₂ is expressed in the central nervous system, including the cerebral cortex, hippocampus, cerebellum, and regions involved in pain processing. Animal studies implicate the receptor in neurotensin-mediated analgesia, making it a potential target for non-opioid pain treatment. Agonist stimulation can induce receptor internalization, which contributes to ERK1/2 activation in recombinant rat NTS₂-expressing cells. Levocabastine, a clinically used histamine H₁ antagonist, also binds NTS₂ and displays assay- and species-dependent functional activity. It is used clinically for allergic disorders, while its NTS₂ activity remains primarily of experimental interest. No NTS₂-selective drug is currently approved for therapeutic use. For more information on NTS2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Mazella J, Sarret P, Vincent JP. Neurotensin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4). Available from: https://doi.org/10.2218/gtopdb/F47/2019.4

Recently viewed